• A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • A study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain

  • An exploratory study to evaluate the effect of rimonabant on hand function in patients with cervical spinal cord injury

    Recruiting

    1 1 1
    Investigated diseases:
    Spain

  • A study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes

    Recruiting

    2 1
    Investigated diseases:
    Poland

  • A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy

    Recruiting

    3 1
    Investigated diseases:
    Bulgaria France Poland Romania Spain

  • A study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations

    Recruiting

    2 1 1 1
    Investigated drugs:
    Denmark France Italy Spain

  • A study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain

  • A study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Spain

  • A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication

    Recruiting

    3 1
    Investigated drugs:
    Belgium Czechia Romania Spain

  • A study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Italy The Netherlands Poland +3

powered by